U.S. markets open in 4 hours 22 minutes

  • S&P Futures

    4,424.50
    -5.50 (-0.12%)
     

  • Dow Futures

    35,151.00
    -4.00 (-0.01%)
     

  • Nasdaq Futures

    15,004.50
    -40.00 (-0.27%)
     

  • Russell 2000 Futures

    2,234.60
    -3.20 (-0.14%)
     

  • Crude Oil

    68.28
    -0.01 (-0.01%)
     

  • Gold

    1,734.30
    +2.60 (+0.15%)
     

  • Silver

    23.34
    -0.05 (-0.20%)
     

  • EUR/USD

    1.1719
    -0.0008 (-0.07%)
     

  • 10-Yr Bond

    1.3420
    0.0000 (0.00%)
     

  • Vix

    16.97
    +0.25 (+1.50%)
     

  • GBP/USD

    1.3814
    -0.0021 (-0.15%)
     

  • USD/JPY

    110.7700
    +0.2300 (+0.21%)
     

  • BTC-USD

    46,169.41
    +118.45 (+0.26%)
     

  • CMC Crypto 200

    1,148.66
    +905.98 (+373.33%)
     

  • FTSE 100

    7,188.13
    +27.09 (+0.38%)
     

  • Nikkei 225

    28,070.51
    +182.36 (+0.65%)
     

Diabetes Devices Market Size Worth $44.6 Billion By 2028 | CAGR 6.6%: Grand View Research, Inc.

·5 min read

SAN FRANCISCO, Aug. 11, 2021 /PRNewswire/ -- The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.

Grand_View_Research_Logo
Grand_View_Research_Logo

Key Insights & Findings:

  • North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches

  • By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate

  • In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage

  • In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements

  • In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage

  • In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices

  • By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies

  • By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment

  • The leading players present in the diabetes devices market are Medtronic plc; Abbott Laboratories; F.Hoffmann-La-Ltd; Bayer AG; Lifescan, Inc.; B Braun Melsungen AG; Lifescan, Inc.; Dexcom Inc.; Insulet Corporation; Ypsomed Holdings; Companion Medical; Sanofi; Valeritas Holding Inc.; Novo Nordisk; Arkray, Inc.; among others

Read 140 page market research report, "Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.

In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.

Grand View Research has segmented the global diabetes devices market on the basis of type, distribution channel, end-use, and region:

  • Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

List of Key Players of Diabetes Devices Market

  • Medtronic plc

  • Abbott Laboratories

  • F.Hoffmann-La-Ltd.

  • Bayer AG

  • Lifescan, Inc.

  • B Braun Melsungen AG

  • Dexcom Inc.

  • Insulet Corporation

  • Ypsomed Holdings

  • Companion Medical

  • Sanofi

  • Valeritas Holding Inc.

  • Novo Nordisk

  • Arkray, Inc.

Check out more studies related to the Global Medical Devices Industry, conducted by Grand View Research:

  • Pessary Market – The global pessary market size is expected to reach USD 547.2 million by 2028, according to a new report by Grand View Research, Inc.

  • Exoskeleton Market – The global exoskeleton market size is expected to reach USD 953.1 million by 2028, according to a new report by Grand View Research, Inc

  • Microneedling Market – The global microneedling market size is expected to reach USD 992.49 million by 2028, registering a CAGR of 7.9% over the forecast period, according to a new report by Grand View Research, Inc.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/diabetes-devices-market-size-worth-44-6-billion-by-2028--cagr-6-6-grand-view-research-inc-301352903.html

SOURCE Grand View Research, Inc.

Recommended Stories

  • Why Virgin Galactic Stock Just Dropped 11%

    Less than 24 hours after The Wall Street Journal confirmed, in its Monday edition, that Virgin Galactic Holdings (NYSE: SPCE) will indeed raise the ticket price for rides on its spaceplane to $450,000 a seat, shares of the space tourism pioneer are plunging 11.1% as of 3:20 p.m. EDT Tuesday. After all, Virgin Galactic itself first announced this price increase on Friday, and investors seemed pretty happy about it at the time. With Virgin Galactic's share price climbing both Friday and Monday, the early read on the company's move appeared to be that demand for space tourism flights was looking so strong that Virgin Galactic had plenty of pricing power, and plenty of room to raise prices to satisfy the demand.

  • The Crypto Daily – Movers and Shakers – August 11th, 2021

    Following Bitcoin’s pullback on Tuesday, a Bitcoin move back through to $46,000 levels would be needed to support the broader crypto market.

  • Oil Steadies With Report Pointing to Shrinking U.S. Inventories

    (Bloomberg) -- Oil was steady after jumping the most in almost three weeks as an industry report pointed to shrinking U.S. gasoline and crude inventories.Futures in New York traded near $68 a barrel after closing 2.7% higher on Tuesday. The American Petroleum Institute reported motor fuel stockpiles fell by 1.11 million barrels last week, according to people familiar with the data. That would be the fourth weekly draw, the longest run of declines since September, if confirmed by official figures

  • 5 Infrastructure Stocks That Look Like Bargains as Senate Passes Bill

    Most construction-related stocks have run up in anticipation of the passage of the $1 trillion bill. But engineering and inspection firms’ shares still seem well-priced.

  • I Want to See a Bit More Bottoming Price Action on LyondellBasell

    During Thursday's "Lightning Round" segment of Mad Money, one caller asked Jim Cramer about LyondellBasell : "It trades for just five times earnings, yet yields 4.7%," and Cramer called that stock "an incredible bargain.

  • Ethereum, Litecoin, and Ripple’s XRP – Daily Tech Analysis – August 10th, 2021

    Following Monday’s rally, steering clear of the day’s pivot levels would deliver further upside for the majors on the day.

  • Exclusive-Great Wall Motor to shift some India investment to Brazil after approval delays -sources

    Great Wall Motor has decided to re-allocate to Brazil a portion of its $1-billion investment in India, as the Chinese automaker has been unnerved by a year-long delay in winning government approvals, three sources told Reuters. The re-allocation, which could range up to $300 million, comes as the sources said the maker of popular sport-utility vehicles (SUVs) and pick-ups was close to acquiring a former Daimler plant in Brazil to build cars. Great Wall has also tasked James Yang, its India president since last year, with the responsibility of assisting with operations in the Latin American nation, said the sources, who have direct knowledge of the matter.

  • Why NGL Energy Partners Plunged 15% Today Despite Higher Oil Prices

    NGL Energy delivered stupendous growth on its top line as crude oil prices rallied, but the market wasn't impressed. NGL Energy's water solutions segment – also its largest -- was the star performer, as the company processed nearly 1.7 million barrels of water per day, up 22% year over year thanks to higher production. NGL Energy is a diversified midstream energy partnership that transports, recycles, and disposes "produced water," which is the water produced as a byproduct of oil and gas extraction.

  • Update On The World’s Most Exciting Oil Play: Interview With Scot Evans

    As the world’s most exciting oil play continues to post stellar results, we had a chance to speak with the man behind the project

  • Inflation risk or profit engine? High car prices are both

    Early this year, Brian Benstock, a Honda and Acura dealer in New York City, convinced his banker it would be smart to buy more vehicles than he could fit onto his parking lot. Rising prices for vehicles and other goods are a problem for the administration of U.S. President Joe Biden.

  • Artificial Intelligence Stocks To Buy And Watch: Will Smarter Wireless Earphones Boost Apple?

    When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Microsoft, Netflix and Nvidia.

  • JPMorgan launches new real-time payments service

    NEW YORK (Reuters) -Global payments giant JPMorgan Chase & Co has launched a real-time payments option that it hopes will increase its edge in the financial industry's battle to handle more of the surging volumes of global digital payments. The new product, called request for pay, lets corporate clients send payment requests to the bank's roughly 57 million retail clients who use its app or website, cutting the cost and time it takes for those companies to get paid, said Cyrus Bhathawalla, the bank's global head of real-time payments. The digital payments product is one of a handful JPMorgan has in the works, as the largest U.S. bank invests heavily in the sector which has grown sharply as more commerce occurs online, a trend further boosted during the coronavirus lockdowns.

  • U.S. Steps Up Pressure on Businesses Over Forced Labor in China

    Amid a broad review of its trade policy with China, the U.S. is stepping up pressure on American businesses to sever ties with the Xinjiang region—the world’s leading producer of cotton and solar-panel materials—over Beijing’s alleged use of forced labor.

  • Steelmakers Surge as U.S. Infrastructure Plan Buoys Demand View

    (Bloomberg) -- Nucor Corp., the biggest U.S. steelmaker, surged to a record high, leading share gains in producers of the metal after the Senate passed a $550 billion infrastructure bill that’s expected to fuel demand.An S&P gauge of steelmakers and related companies advanced to the highest since August 2008, with Nucor climbing as much as 10% and U.S. Steel Corp. rising more than 7%. Producers of other industrial metals also advanced. Alcoa Corp. rose as much as 8.9% and Freeport-McMoRan Inc. g

  • This Stock Is Radically Transforming a Multitrillion-Dollar Industry

    As the restaurant industry evolves into "ghost kitchens" and more people order food online, one tiny company is leading the way.

  • Analyst Report: PG&E Corporation

    PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.4 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.

  • Human rights claims undermine China's investment abroad, report finds

    The Business & Human Rights Resource Centre, a global nongovernmental organisation (NGO), logged 679 charges of human rights abuse against Chinese companies operating abroad between 2013 and 2020. Metals and mining drew the most allegations - 236, or 35% of the total. Peru, the world's second-biggest copper producer, and China's neighbour Myanmar, a leading supplier of tin and rare earth ore, were named as hotspots.

  • Boston Beer, PepsiCo team up for Mountain Dew-branded alcoholic drinks

    Myles Udland, Brian Sozzi, and Julie Hyman discuss Boston Beer Company and PepsiCo plans to partner together to launch a new Hard Mountain Dew and what this partnership could entail for future drink endeavors.

  • BioNTech says has supplied over 1 bln vaccines

    BioNTech and its partner Pfizer have supplied more than one billion doses of their COVID-19 vaccine.That's according to the German biotech group Monday (August 9).The supply tally is up from more than 700 million doses announced by BioNTech in June.The company said in a statement it expects to make just under $19 billion in revenue from the vaccine this year - up from a previous forecast in May.That's based on delivery contracts for more than 2.2 billion doses so far.BioNTech's optimism comes after Pfizer last month also raised its forecast for its share of 2021 vaccine sales to $33.5 billion.BioNTech added that it and Pfizer believe a third dose of its vaccine 'has the potential to preserve the highest levels of protection against all currently tested variants of the virus - that includes the highly infectious Delta variant.It does, though, plan to start testing a vaccine adjusted to Delta on humans this month.

  • API data show U.S. oil inventories down 816,000 barrels: sources

    The American Petroleum Institute on Tuesday said U.S. crude-oil inventories fell 816,000 barrels last week, according to sources. Gasoline inventories were seen down 1.14 million barrels, while distillate stocks rose 673,000 barrels. Inventories at Cushing, Oklahoma, the delivery hub for Nymex oil futures, fell 413,000 barrels. The Energy Information Administration will release official weekly data Wednesday morning. Analysts surveyed by S&P Global Platts, on average, look for the EIA to show cr